It is a pharma public limited company based in Ratlam, Madhya Pradesh, India, established in 1988.
1988 | Ratlam, Madhya Pradesh, India | ActiveHi-Tech Drugs Limited, a active public limited company, was established on 25 August 1988 in Ratlam, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MP1988PLC004749. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹4.25 Cr and a paid-up capital of ₹4.10 Cr.
It upholds a compliant status. Its leadership includes Rajeev Kumar Jain (Director), Daluram Agrawal (Director), Sanjeev Kumar Jain (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at B-126 Deen Dayal Nagar, Ratlam, Madhya Pradesh, 457001.
U24239MP1988PLC004749
004749
25 August 1988
₹4.25 Cr
₹4.10 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Hi-Tech Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Kumar Jain | Director | 25 Aug 1988 | Current |
| Daluram Agrawal | Director | 06 Sep 1988 | Current |
| Sanjeev Kumar Jain | Director | 25 Aug 1988 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hi-Tech Drugs Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2021, Hi-Tech Drugs had a promoter holding of 46.30% and a public holding of 53.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hi-Tech Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hi-Tech Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hi-Tech Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Hi-Tech Drugs Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Hi-Tech Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior. was documented.
The activity Daluram Agrawal was appointed as a Director was appointed as a Director on 06 Sep 1988 & has been associated with this company since 37 years 3 months . was completed.
Progress on Rajeev Kumar Jain was appointed as a Director was appointed as a Director on 25 Aug 1988 & has been associated with this company since 37 years 3 months . was documented.
The activity Sanjeev Kumar Jain was appointed as a Director was appointed as a Director on 25 Aug 1988 & has been associated with this company since 37 years 3 months . was completed.
Progress on Hi-Tech Drugs Limited was registered on 25 Aug 1988 with Roc Gwalior & aged 37 years 3 months as per MCA records. was documented.
The CIN of Hi-Tech Drugs Limited is U24239MP1988PLC004749.
Hi-Tech Drugs Limited is headquartered at B-126 Deen Dayal Nagar, Ratlam, Madhya Pradesh, 457001.
Hi-Tech Drugs Limited was incorporated on 25 August 1988.
The current directors of Hi-Tech Drugs Limited are
The primary industry of Hi-Tech Drugs Limited is Pharma.
Hi-Tech Drugs Limited is unlisted.
The authorized capital of Hi-Tech Drugs Limited is ₹4.25 Cr, and the paid-up capital is ₹4.10 Cr.
The compliance status of Hi-Tech Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX